
Patients who take either dose of Teva’s investigational treatment for chronic migraine improve more than those taking a placebo according …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

